Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRelx Regulatory News (REL)

Share Price Information for Relx (REL)

Share Price is delayed by 15 minutes
Get Live Data
2,602.00    -14.00 (-0.54%)
Bid:
2,601.00
Ask:
2,603.00
Spread: 2.00 (0.077%)
Market Cap: £45.85b
REL Live PriceLast checked at - London Stock Exchange

Intraday Relx Share Chart

Directorate Change

13 Feb 2025 07:15

RNS Number : 9240W
RELX PLC
13 February 2025
 

RELX PLC announces Non-Executive Director appointment and other Board changes

 

RELX PLC today announces the appointment of Andy Halford as a Non-Executive Director, with effect from the conclusion of the 2025 Annual General Meeting (AGM), to be held on 24 April 2025, subject to his election at the AGM. The Company also announces the retirement of Robert MacLeod from the Board.

 

Mr Halford is currently Chief Financial Officer of Aareal Bank, a leading international specialist property bank. Prior to joining Aareal Bank, Mr Halford was Chief Financial Officer of Standard Chartered plc from 2014 to 2024, and Chief Financial Officer of Vodafone Group Plc from 2005 to 2014. Mr Halford also served as a Non-Executive Director and Audit Committee Chair of Marks and Spencer Group plc from 2013 to 2022 and was appointed as Senior Independent Director of that board in 2018. Mr Halford qualified as a chartered accountant at Price Waterhouse LLP. He holds a Bachelor of Arts degree in Industrial Economics from Nottingham University.

 

Having served as a Non-Executive Director since 2016, and currently holding the role of Chair of the Remuneration Committee, Robert MacLeod will retire from the Board following the conclusion of the Company's AGM. Alistair Cox will succeed Mr MacLeod as Chair of the Remuneration Committee with effect from the conclusion of the AGM, subject to his re-election by shareholders at the AGM. 

 

Commenting on these changes, Paul Walker, Chair said: 

"I am very much looking forward to Andy joining our Board. Andy is a highly accomplished and well-respected senior executive with a strong financial background and reputation for delivering shareholder value in major, complex, international organisations. With his considerable experience, I am confident Andy will make a significant contribution to the RELX Board.

On behalf of the Directors, I would like to thank Robert for the valuable service that he has given RELX, as a member of the Board and in performing the role of Chair of the Remuneration Committee. Robert leaves RELX with our very best wishes for the future."

 

Save as disclosed above, there are no additional details to disclose under Listing Rule 6.4.8R (1) to (6) in respect of the appointment of Mr Halford.

 

 

 

-ENDS-

 

 

ENQUIRIES:

 

Colin Tennant (Investors)

+44 (0)20 7166 5751

Paul Abrahams (Media)

+44 (0)20 7166 5724

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDDBXBDGUD
Date   Source Headline
2nd Jan 20255:14 pmRNSBlock listing Interim Review
2nd Jan 20253:42 pmRNSTotal Voting Rights
16th Dec 20245:34 pmRNSAdditional Listing
9th Dec 20241:50 pmRNSDirector Declaration
6th Dec 20247:00 amRNSNon-Discretionary Share Buyback Programme
3rd Dec 20245:23 pmRNSTransaction in Own Shares
2nd Dec 20245:44 pmRNSTransaction in Own Shares
2nd Dec 202411:57 amRNSTotal Voting Rights
29th Nov 20245:39 pmRNSTransaction in Own Shares
28th Nov 20245:22 pmRNSTransaction in Own Shares
27th Nov 20245:26 pmRNSTransaction in Own Shares
26th Nov 20245:19 pmRNSTransaction in Own Shares
25th Nov 20245:37 pmRNSTransaction in Own Shares
22nd Nov 20245:12 pmRNSTransaction in Own Shares
21st Nov 20245:47 pmRNSTransaction in Own Shares
20th Nov 20245:41 pmRNSTransaction in Own Shares
19th Nov 20245:54 pmRNSTransaction in Own Shares
18th Nov 20245:38 pmRNSTransaction in Own Shares
15th Nov 20245:28 pmRNSTransaction in Own Shares
15th Nov 202411:07 amRNSAdditional Listing
14th Nov 20245:30 pmRNSTransaction in Own Shares
13th Nov 20245:44 pmRNSTransaction in Own Shares
12th Nov 20245:47 pmRNSTransaction in Own Shares
11th Nov 20245:32 pmRNSTransaction in Own Shares
11th Nov 20242:21 pmRNSTransaction in Own Shares - Correction
8th Nov 20245:15 pmRNSTransaction in Own Shares
7th Nov 20245:48 pmRNSTransaction in Own Shares
6th Nov 20245:13 pmRNSTransaction in Own Shares
5th Nov 20245:16 pmRNSTransaction in Own Shares
4th Nov 20245:37 pmRNSTransaction in Own Shares
1st Nov 20245:23 pmRNSTransaction in Own Shares
1st Nov 20243:49 pmRNSTotal Voting Rights
31st Oct 20245:50 pmRNSTransaction in Own Shares
30th Oct 20245:30 pmRNSTransaction in Own Shares
29th Oct 20246:01 pmRNSTransaction in Own Shares
28th Oct 20245:52 pmRNSTransaction in Own Shares
25th Oct 20245:31 pmRNSTransaction in Own Shares
24th Oct 20245:12 pmRNSTransaction in Own Shares
24th Oct 20247:00 amBUSTRADING UPDATE – October 2024
23rd Oct 20245:04 pmRNSTransaction in Own Shares
22nd Oct 20245:10 pmRNSTransaction in Own Shares
22nd Oct 202411:18 amRNSAdditional Listing
21st Oct 20245:30 pmRNSTransaction in Own Shares
18th Oct 20245:14 pmRNSTransaction in Own Shares
17th Oct 20245:51 pmRNSTransaction in Own Shares
16th Oct 20245:27 pmRNSTransaction in Own Shares
15th Oct 20245:19 pmRNSTransaction in Own Shares
14th Oct 20245:32 pmRNSTransaction in Own Shares
11th Oct 20245:09 pmRNSTransaction in Own Shares
10th Oct 20245:27 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.